Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

SHBG may be a useful early indicator and treatment target for PCOS.

Finasteride helps reduce heart issues and improves heart function.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Genes and hormones cause hair loss, with four genes contributing equally.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Low prolactin in young women may increase heart and metabolism risks.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Sinapic acid may help hair growth by activating a specific cell pathway.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.